← Browse by Condition

Medical Condition

dementia

Total Trials

21

Recruiting Now

21

Trial Phases

Phase 4, Phase 1

ClinicalMetric tracks all active clinical trials for dementia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — dementia Clinical Trials

How many clinical trials are currently recruiting for dementia?

ClinicalMetric currently tracks 21 actively recruiting clinical trials for dementia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 21. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for dementia?

dementia research spans Phase 1 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a dementia clinical trial?

Eligibility criteria for dementia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

1

Phase 4

1

Top Sponsors

Emory University 1 trial

Johns Hopkins University 1 trial

Albert Einstein College of Medicine 1 trial

Laval University 1 trial

Fu Jen Catholic University 1 trial

Recruiting Clinical Trials

Effect of Cognitive Empathy Training on Dementia Caregivers

Emory University

HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms

Johns Hopkins University

5-Cog 2.0: A Pragmatic Clinical Trial

Albert Einstein College of Med...

CONSTELLATIONS Living Lab: Improving the Care Transitions of Older Adults Living with Neurocognitive Disorders

Laval University

Dementia in Fiction and Clinical Narratives

Fu Jen Catholic University

Effects of Jing Si Herbal Tea on Quality of Life and Sleep in Dementia and Their Caregivers

National Cheng Kung University

Web-based Cognitive Behavioral Treatment for Insomnia in Dementia Caregivers

University of South Florida

Dance Workshop for Institutionalized Seniors With Behavioral and Psychological Symptoms of Dementia

Centre Hospitalier Emile Roux

Vascular mEchanisms in, Stroke, dePression, dementiA, and deliRum: The VESPAR Project

University of Leicester

Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia

Hebrew SeniorLife

Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia

Advanced Technology & Communic...

Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

University of Alabama, Tuscalo...

Aerobic Exercise for Older Adults at Increased Risk of Alzheimer's Disease and Related Dementias

University of Calgary

Large Language Model for Understanding and Monitoring Elderly Neurocognition

Northumbria Healthcare NHS Fou...

Research on the Early and Prognosis Diagnosis of Vascular Dementia

National Taiwan University Hos...

Alzheimer Prevention Trials (APT) Webstudy

University of Southern Califor...

EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality

Future Genetics Limited

NYSCF Scientific Discovery Biobank

New York Stem Cell Foundation ...

Shanghai At Risk for Alzheimer's Disease: a Cohort Study

Ruijin Hospital

NCT07485283 Phase 4

Recombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and Dementia

Tor Biering-Sørensen

NCT04396873 Phase 1

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

National Institute of Mental H...

Related Conditions

alzheimer disease (8) cognitive impairment (3) alzheimer s disease (3) depression (2) neurodegenerative diseases (2) neurocognitive disorders (2) diabetes mellitus (2) als (2) caregivers of people living with dementia (1) hearing loss (1) neurocognitive decline (1) caregiver burden (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology